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This Month in the Journal
Admixture mapping is an approach to gene mapping that
makes use of population-specific variation in a trait. The
basic idea is to look for association of locus ancestry
with the trait in populations that are admixed (i.e., that
are derived from mixing of the populations that show
differences in the trait). This month in the Journal, Paul
McKeigue describes recent advances in admixture map-
ping, including statistical methods and appropriate mark-
er sets, that are making this type of approach increasing-
ly feasible. This approach is attractive because it should
be more powerful and should require fewer markers
than many traditional gene-mapping methods. However,
there are still some challenges in the use of these meth-
ods, as Dr. McKeigue explains. He further addresses the
types of traits and populations for which these methods
will be most useful.
Our second review article this month is by Dirk Klein-
jan and Veronica van Heyningen; in it, they discuss long-
range control of gene expression. Especially for genes
with complex expression patterns, cis regulatory elements
can lie at great distances from the transcriptional unit.
These elements can serve different functions, such as pro-
viding a docking site for DNA-binding proteins or con-
trolling chromatin structure in the region. Several ex-
amples of long-range control of expression are given,
and the methods for finding these elements are discussed,
as are implications of the identification of these elements,
in terms of both understanding how genes are regulated
and what the elements mean for mutation screens.
Genetic Analysis of AR and Prostate Cancer, by
Freedman et al. (p. 82)
Several studies have looked for association between varia-
tion in the gene for the androgen receptor (AR) and risk
of prostate cancer, and many of these have yielded posi-
tive results. AR is a biologically plausible candidate gene
because androgens are important for the progression of
prostate cancer, and antiandrogens are routinely used in
its treatment. However, some researchers do not find
evidence of this association, and, in the studies with
positive results, there hasn’t been a consistent model for
the genotype-phenotype correlation. This led Freedman
et al. to systematically evaluate variation in AR in a mul-
tiethnic case-control study comprising 14,000 subjects.
Freedman et al. report no association in this sample. A
polymorphism of particular interest in AR, because of
its effect on AR function, is a CAG repeat in the coding
region. Freedman et al. found no evidence of association
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of this repeat with risk of prostate cancer using any
previously described model of genotype-phenotype cor-
relation. There was also no association of prostate can-
cer risk with common SNPs or common haplotypes in
AR, nor was there evidence of protein-altering mutations
in the case sample. Thus, if the AR locus has any effect
on prostate cancer risk, Freedman et al. think the effect
must be either very small or present in only a subgroup
of patients.
Analysis of Meiosis in Human Fetal Oocytes, by Lenzi
et al. (p. 112)
Trisomy 21 Maternal Age and Recombination, by
Lamb et al. (p. 91)
Two papers in this issue examine the association of mei-
otic errors in oocytes with chromosomal aneuploidy. The
authors of both papers believe that recombination in fe-
male germ cells is a key factor in nondisjunction in these
cells, but they use different approaches to examine this
more carefully.
Lenzi et al. used human female oocytes to study regu-
lation of recombination during meiosis. They report a
high degree of variability between oocytes in the number
of MLH1-MLH3 foci, which are thought to mark the
areas where mature crossover structures between homo-
logous chromosomes will form. A reduced ability to form
the proper structures in some oocytes would have conse-
quences for recombination and, ultimately, proper chro-
mosome segregation during meiosis.
Rather than look at oocytes directly, Lamb et al. ex-
amined recombination patterns in trisomy 21 cases of
maternal meiosis I origin. They were specifically inter-
ested in the relationship between maternal age and in-
creased incidence of chromosomal aneuploidy. Although
no significant differences were observed across maternal
age groups—in terms of the overall amount of recom-
bination on the nondisjoined chromosomes 21—they
did find age-dependent differences in the placement of
these exchanges. For example, the youngest maternal-
age group had the highest proportion of recombinations
in the telomeric region, which are more likely to pre-
dispose to nondisjunction. With increasing maternal
age, the distribution of recombination events associated
with trisomy 21 became more similar to that of a sample
with normal chromosome segregation. Lamb et al. pos-
tulate that there are different risk factors for trisomy
21 at different maternal ages. In younger mothers, this
appears to be the presence of recombination patterns
that are more susceptible to chromosome 21 nondis-
junction. In older women, an increase in recombination-
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independent risk factors for nondisjunction leads to the
maternal-age effect.
Malic Enzyme and Epilepsy Susceptibility, by
Greenberg et al. (p. 139)
A locus on chromosome 18 was implicated elsewhere in
common forms of adolescent-onset idiopathic general-
ized epilepsy (IGE). This locus appears to have involve-
ment in at least three forms of common IGE—juvenile
myoclonic epilepsy, juvenile absence epilepsy, and epi-
lepsy with generalized tonic-clonic seizures—whereas
other loci involved in common IGE seem to be more
specific to a certain seizure type. Greenberg et al. looked
for association of IGE with genes in the chromosome 18
region and report a haplotype in the gene encoding malic
enzyme 2 (ME2) that confers risk for IGE to homozy-
gous carriers, compared with all other genotypes. ME2
is an enzyme that is indirectly involved in synthesis of
GABA, one of the main inhibitory neurotransmitters in
the CNS. This led the authors to develop a model in
which a common underlying factor in many cases of
adolescent-onset IGE might be variation, in ME2, that
affects GABA synthesis in brain and leads to a change in
the threshold for cortical excitability. Alteration of the
threshold could increase the susceptibility of those in-
dividuals to seizures triggered by mechanisms that are at
least partly governed by variation in the genetic regions
that show linkage to more-specific seizure types. If this
model is true, it would help to explain the phenotypic
variability for common IGE that is present even within
affected families.
Mapping of QTL for Telomere Length, by
Vasa-Nicotera et al. (p. 147)
Telomere length is an important determinant of cellu-
lar senescence. In proliferating somatic cells, telomeres
shorten with age, and this shortening has been associated
with age-related disorders, such as cardiovascular dis-
ease and arthritis. Because of this association with aging
and the implications of telomere length in cancer, Vasa-
Nicotera et al. wanted to look for QTLs involved in the
determination of telomere length. This seemed a plau-
sible proposition, because, although the telomere length
in a particular person is fairly characteristic, there is varia-
tion in telomere length between people, and that trait
has been estimated to have high heritability. In fact, the
authors’ results were promising. They used Southern blots
to measure telomere restriction-fragment lengths from
leukocytes. These measurements were then used as a
quantitative trait in a genome scan. Vasa-Nicotera et al.
found significant linkage to a locus on chromosome 12
that contains the DDX11 helicase gene. This is an ob-
vious candidate gene, because other helicases are known
to have roles in telomere maintenance. A preliminary
analysis with markers in DDX11 did not provide evi-
dence for an association with telomere length, but the
authors are currently pursuing a more detailed analysis
of this gene.
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